Skip to content

HPLC analysis published for every batchTHC < 0.3%Shipped from France10% off when you sign up

Machaeriol A

Hexahydrodibenzopyran from Machaerium, with no retained CB1 affinity, covered by the French generic clause.

Level of detail

C₂₄H₂₈O₂

Harm-reduction warning

No characterised human dose: animal / in vitro data only. Effect profile, safety margin and acute toxicity are not documented in human clinical practice. Extremely potent compound: severe effects, seizures and deaths reported in the literature.

Data sheet

Names

IUPAC name
(6aS,9S,10aS)-6,6,9-trimethyl-3-[(E)-2-phenylethenyl]-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-1-ol

Identifiers

Formula
C₂₄H₂₈O₂
Molar mass
348.50 g/mol
InChIKey
KCNFZTIIENBEPU-TUCATBTLSA-N

Class

Family
Phytocannabinoid

Legal status

France
Narcotic: generic clause
International
Unscheduled
See the legal framework

Updated on

Receptors and activity

  1. CB1Modulator5 out of 100

    aucune constante d'affinité publiée ; déplacement de 18,4 % à 10 µM (Muhammad et coll., 2023) ; aucune affinité CB1 retenue (Muhammad et coll., 2001)

  2. CB2Modulator5 out of 100

    aucune constante d'affinité publiée ; déplacement de 24,4 % à 10 µM (Muhammad et coll., 2023)

Bar length shows the relative strength of the interaction, as an indication.

Subjective signature

Calm
5 out of 100
Relaxation of body and mind; reduced mental noise without marked drowsiness.
Clarity
5 out of 100
Sustained attention and clear thinking; functional lucidity, not euphoria.
High
5 out of 100
Euphoria and sensory intensity; altered perception of time and space.
Appetite
5 out of 100
Stimulation of hunger and of taste appreciation (the “munchies” effect).
Sleep
5 out of 100
Sedative effect: aids sleep onset and the continuity of deep sleep.
Editorial estimate, not clinical.

Pharmacology

Machaeriol A is a hexahydrodibenzopyran isolated from a plant of the genus Machaerium Pers., a legume first identified as Machaerium multiflorum, and described in 2001 by Muhammad et al. at the University of Mississippi: it is the first report of this family of compounds outside the genus Cannabis. Its structure recalls that of Δ9-THC, with a styryl chain in place of the pentyl chain. It has no CB1 affinity retained in the published studies and displaces only 24.4% of the ligand at CB2 at 10 µM, with no published Ki constant. No human data were found in the sources consulted. In France, it is classed as a narcotic under the generic clause arising from the ANSM decisions of 22 May and 3 June 2024.

History

Source
Machaerium Pers. (family Fabaceae), a plant first assigned to Machaerium multiflorum. The compound was extracted from the stem bark with an ethanol extract (Muhammad et al., 2023).

Biosynthetic pathway

Biosynthetic pathway: none is described in the sources consulted for machaeriol A. Its authors classify it among the aralkyl phytocannabinoids, a rare class of phytocannabinoids produced by a higher plant, analogous to the cannabinoids of the genus Cannabis (Muhammad et al., 2023).

References

Structured data

SMILES
C[C@H]1CC[C@H]2[C@H](C1)c1c(O)cc(/C=C/c3ccccc3)cc1OC2(C)C
InChIKey
KCNFZTIIENBEPU-TUCATBTLSA-N

Machine-readable entry (JSON)

LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.